An observational study in Drug-specific Antibodies, sponsored by Nanfang Hospital, Southern Medical University. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2022-11-04.
Sponsored by Nanfang Hospital, Southern Medical University · Observational
Blood samples for hemolytic anemia in patients treated with one or more of the antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin were screened for the production of drug antibodies.
The widespread use of antibiotics and anti-tumor drugs in clinical practice leads to poor efficacy or even toxic side effects and other adverse events, which are often related to the immune response caused by the cells adsorption or binding because of the long-term use of drugs to cause the generation of antibodies or drug decomposition.The immune hemolytic anemia caused by antibiotics is more common.In this study, the remaining blood samples of patients who developed hemolytic anemia using one or more antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium and vancomycin were preliminarily screened to determine which drugs caused hemolytic anemia.The types of diseases and antibiotics used in patients with drug-induced hemolytic anemia were also analyzed.The positive rate of drug antibody production was calculated and the difference of drug antibody production mechanism was analyzed.The blood samples of the positive patients and some negative patients were collected and preserved to prepare for the follow-up study.
Nanfang Hospital, Southern Medical University is the lead sponsor of 488 studies on the registry; 213 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients treated with one or more of the antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Blood samples for hemolytic anemia in patients treated with piperacillin were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with amoxicillin were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with cefazolin were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with cefuroxime were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with ceftriaxone were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with cefoxitin sodium were screened for the production of drug antibodies.
Blood samples for hemolytic anemia in patients treated with vancomycin were screened for the production of drug antibodies.
To compare the positive rate of drug antibody between different drugs.
The drug-induced hemolytic anemia test kit (microcolumn gel method) was used to determine whether drug antibodies were produced in the participates.
Time frame: through study completion, an average of 3 years.
Started Oct 2021 (actual). Primary completion is estimated for Dec 2023, 26 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanfang Hospital, Southern Medical University →